Scholtz & Company’s Colgate-Palmolive CL Stock Holding History

Scholtz & Company’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,304	Closed	-$365K	–	53
2019 Q4	$365K	Buy	+5,304	New	+$362K	0.21%	51

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Scholtz & Company's CL Position: Q1 2020 in Review

Scholtz & Company sold out of Colgate-Palmolive (CL) in Q1 2020, closing a stake of 5,304 shares — an estimated $365K sold.

Scholtz & Company first reported a position in CL in Q4 2019 and held it in 1 quarter. The position peaked at $365K in Q4 2019. 1,493 funds tracked by Wall St. Rank hold CL as of Q1 2020.

Scholtz & Company reported no remaining Colgate-Palmolive position as of Q1 2020 after selling out during the quarter.
Scholtz & Company sold 5,304 Colgate-Palmolive shares in Q1 2020, an estimated $365K.
Scholtz & Company first reported a position in Colgate-Palmolive in Q4 2019 and held it in 1 quarter.
Scholtz & Company's Colgate-Palmolive position peaked at $365K in Q4 2019.
1,493 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2020.

Based on Scholtz & Company's 13F filing for Q1 2020, filed 14 May 2020.